Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronidase added to bupivacaine for TAP block after abdominal hysterectomy
PACTR202501501517422Phase 3Recruiting
- Sponsor
- Al-Azhar University
- Start
- Dec 2024
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of bupivacaine and hyaluronidase in postoperative pain (2 arms), sponsored by Al-Azhar University. Primary endpoint: postoperative VAS score. Started Dec 2024; status: recruiting.
02
Drugs
bupivacainehyaluronidase
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202501501517422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202501501517422.